-+ 0.00%
-+ 0.00%
-+ 0.00%

ARRIVENT ANNOUNCES INITIAL PHASE 1 DATA FOR CDH17-TARGETED ADC ARR-217 IN PATIENTS WITH GASTROINTESTINAL CANCERS AT ESMO CONGRESS 2026

路透·10/25/2026 13:00:01

请登录查看新闻详情